Roswell Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Roswell Biotechnologies's estimated annual revenue is currently $2.4M per year.
- Roswell Biotechnologies's estimated revenue per employee is $77,500
- Roswell Biotechnologies's total funding is $37M.
Employee Data
- Roswell Biotechnologies has 31 Employees.
- Roswell Biotechnologies grew their employee count by -6% last year.
Roswell Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 150% | N/A | N/A |
#5 | $1.4M | 9 | 0% | N/A | N/A |
#6 | $11.5M | 74 | -12% | N/A | N/A |
#7 | $0.4M | 275 | 10% | $236.7M | N/A |
#8 | $4M | 51 | -74% | $160M | N/A |
#9 | $2.5M | 16 | 33% | N/A | N/A |
#10 | $3.3M | 21 | -12% | N/A | N/A |
What Is Roswell Biotechnologies?
Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their new molecular electronics sequencing platform designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeqᅢᄁ¬ダᅡᄁ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.
keywords:N/A$37M
Total Funding
31
Number of Employees
$2.4M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Roswell Biotechnologies News
Twenty years after the field underwent a dramatic hype cycle, Roswell Biotechnologies is using single molecules to make better biosensor...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 31 | N/A | N/A |
#2 | $3.6M | 31 | N/A | N/A |
#3 | $3.6M | 31 | N/A | N/A |
#4 | $6M | 31 | 0% | N/A |
#5 | $6.7M | 31 | -9% | N/A |